A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Dothan, AL · +94 more sites
8 recruiting crohn's disease studies with a site in Dothan, AL.
Sponsor: Hoffmann-La Roche
Dothan, AL · +94 more sites
Sponsor: AbbVie
Dothan, AL · +59 more sites
Sponsor: Merck Sharp & Dohme LLC
Dothan, AL · +86 more sites
Sponsor: Eli Lilly and Company
Dothan, AL · +34 more sites
Sponsor: Hoffmann-La Roche
Dothan, AL · +60 more sites
Sponsor: AbbVie
Dothan, AL · Mobile, AL · +62 more sites
Sponsor: Janssen Research & Development, LLC
Dothan, AL · Mobile, AL · +37 more sites
Sponsor: Takeda
Dothan, AL · +40 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.